(Q52423311)
Statements
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. (English)
P Jakobsen
L Bastholt
M Dalmark
P Pfeiffer
D Petersen
S B Gjedde
E Sandberg
C Rose
O S Nielsen
H T Mouridsen
1 January 1991
28
6
465-469
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference